Journal
JOURNAL OF IMMUNOLOGY
Volume 186, Issue 3, Pages 1554-1563Publisher
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.1003005
Keywords
-
Categories
Funding
- National Institutes of Health [AI050143]
- American Cancer Society
Ask authors/readers for more resources
CD22 is a member of the sialic acid-binding Ig-like lectin (Sigler) family that is known to be a regulator of B cell signaling. Its B cell-specific expression makes it an attractive target for immunotoxin-mediated B cell depletion therapy for the treatment of B cell lymphomas and autoimmune diseases. Although CD22 is well documented to be an endocytic receptor, it is believed that after internalization, it is targeted for degradation. We show in this study that CD22 is instead constitutively recycled to the cell surface. We also find that glycan ligand-based cargo is released from CD22 and accumulates intracellularly as CD22 recycles between the cell surface and endosomal compartments. In contrast, Abs to CD22 do not accumulate but remain bound to CD22 and recycle to the cell surface. The results have implications for development of agents that target CD22 as an endocytic receptor for delivery of cytotoxic cargo to B cells. The Journal of Immunology, 2011, 186: 1554-1563.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available